Total Payments
$2,328
2024 Payments
$367.79
Companies
22
Transactions
133
Medicare Patients
8,319
Medicare Billing
$285,031
Payment Breakdown by Category
Food & Beverage$2,328 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,328 | 133 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $371.93 | 27 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $253.30 | 17 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $223.40 | 17 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $202.86 | 12 | $0 (2024) |
| Baxter Healthcare | $151.06 | 3 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $146.21 | 8 | $0 (2023) |
| PFIZER INC. | $144.89 | 7 | $0 (2024) |
| Edwards Lifesciences Corporation | $129.60 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $97.68 | 6 | $0 (2024) |
| Amgen Inc. | $92.90 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $367.79 | 18 | PFIZER INC. ($100.68) |
| 2023 | $569.49 | 18 | Baxter Healthcare ($151.06) |
| 2021 | $18.48 | 1 | Medtronic, Inc. ($18.48) |
| 2020 | $47.47 | 4 | Janssen Pharmaceuticals, Inc ($34.58) |
| 2019 | $390.90 | 28 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($120.60) |
| 2018 | $477.61 | 31 | Boehringer Ingelheim Pharmaceuticals, Inc. ($111.23) |
| 2017 | $456.67 | 33 | Boehringer Ingelheim Pharmaceuticals, Inc. ($148.26) |
All Payment Transactions
133 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.00 | General |
| Category: Cardiovascular | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/24/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: CDS - BG Mini Plus_RM | ||||||
| 09/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Cardiology | ||||||
| 07/07/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/04/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Not Applicable | ||||||
| 06/03/2024 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $42.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/28/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/31/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $27.35 | General |
| Category: Not Applicable | ||||||
| 01/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/19/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/15/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $27.37 | General |
| Category: Heart Failure | ||||||
| 12/06/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.98 | General |
| Category: Cardiovascular | ||||||
| 11/29/2023 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $46.31 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/27/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/20/2023 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $53.62 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,065 | 2,482 | $330,522 | $67,856 |
| 2022 | 15 | 2,166 | 2,606 | $374,762 | $74,229 |
| 2021 | 15 | 2,109 | 2,562 | $373,045 | $76,749 |
| 2020 | 18 | 1,979 | 2,439 | $316,443 | $66,197 |
Total Patients
8,319
Total Services
10,089
Medicare Billing
$285,031
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 275 | 316 | $66,629 | $21,039 | 31.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 164 | 170 | $69,700 | $8,954 | 12.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 83 | 84 | $23,940 | $8,416 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $14,422 | $5,570 | 38.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 48 | $8,640 | $4,470 | 51.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 555 | 701 | $24,535 | $4,410 | 18.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 94 | 94 | $38,540 | $4,399 | 11.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 412 | 518 | $18,130 | $3,027 | 16.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 35 | 35 | $33,355 | $1,921 | 5.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 81 | 82 | $3,608 | $1,264 | 35.0% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 71 | 155 | $3,565 | $1,224 | 34.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 46 | 46 | $18,308 | $1,174 | 6.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 79 | 80 | $2,400 | $819.75 | 34.2% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 55 | 56 | $3,024 | $711.76 | 23.5% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 13 | 13 | $676.00 | $257.27 | 38.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 17 | 29 | $1,050 | $200.10 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 335 | 414 | $87,924 | $27,497 | 31.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 70 | 73 | $20,805 | $7,764 | 37.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 129 | 131 | $53,710 | $7,261 | 13.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $16,060 | $5,668 | 35.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 103 | 103 | $42,230 | $4,943 | 11.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 457 | 627 | $21,945 | $3,616 | 16.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 443 | 532 | $18,620 | $3,445 | 18.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 55 | 55 | $52,415 | $3,110 | 5.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 30 | 34 | $6,120 | $2,744 | 44.8% |
About Dr. Michael Layden, M.D
Dr. Michael Layden, M.D is a Cardiovascular Disease healthcare provider based in Queensbury, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194728774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Layden, M.D has received a total of $2,328 in payments from pharmaceutical and medical device companies, with $367.79 received in 2024. These payments were reported across 133 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,328).
As a Medicare-enrolled provider, Layden has provided services to 8,319 Medicare beneficiaries, totaling 10,089 services with total Medicare billing of $285,031. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Queensbury, NY
- Active Since 05/27/2005
- Last Updated 07/29/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1194728774
Products in Payments
- PRADAXA (Drug) $353.32
- LifeVest (Device) $253.30
- XARELTO (Drug) $223.40
- ELIQUIS (Drug) $202.97
- Hillrom - Carnation Ambulatory Monitor (Device) $151.06
- MULTAQ (Drug) $125.89
- Arcalyst (Drug) $87.42
- BRILINTA (Drug) $85.18
- Repatha (Biological) $77.22
- PRALUENT (Drug) $76.97
- PRALUENT ALIROCUMAB INJECTION (Biological) $69.68
- WATCHMAN (Device) $59.39
- VERQUVO (Drug) $59.30
- PRALUENT (Biological) $49.86
- CARDIOMEMS (Device) $41.63
- CAMZYOS (Drug) $39.60
- FUROSCIX (Drug) $29.06
- EVKEEZA (Biological) $26.67
- WAINUA (Drug) $26.07
- ENTRESTO (Drug) $25.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Queensbury
Henry Tan, Md, MD
Cardiovascular Disease — Payments: $4,471
Cardiovascular Disease $4,471
Gregory Kelly, M.d, M.D
Cardiovascular Disease — Payments: $3,012
Cardiovascular Disease $3,012
Atilla Kayalar, M.d, M.D
Cardiovascular Disease — Payments: $2,987
Cardiovascular Disease $2,987
Scott Munro, M.d, M.D
Cardiovascular Disease — Payments: $2,271
Cardiovascular Disease $2,271
David Judkins, M.d, M.D
Cardiovascular Disease — Payments: $1,419
Cardiovascular Disease $1,419
Patrick Rowley, M.d, M.D
Cardiovascular Disease — Payments: $483.30
Cardiovascular Disease $483.30